Sign up to save your podcasts
Or
Share 30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 27 Applying Six Sigma and Other Continuous Improvement Tools
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 27 Applying Six Sigma and Other Continuous Improvement Tools
This podcast episode explores the application of Six Sigma and continuous improvement tools in natural product manufacturing, particularly focusing on cannabis and psychedelic compounds. The discussion covers:
- The DMAIC (Define, Measure, Analyze, Improve, Control) methodology and its practical applications
- Quality by Design (QbD) principles and risk management frameworks
- Real-world case studies, including improving terpene profile consistency in cannabis extracts and controlling impurities in pharmaceutical manufacturing
The episode emphasizes how these quality control principles help manufacturers maintain consistency, safety, and efficacy in natural product manufacturing while meeting regulatory requirements.
View all episodes
By Jim Mitchell and Google NotebookLMThis podcast episode explores the application of Six Sigma and continuous improvement tools in natural product manufacturing, particularly focusing on cannabis and psychedelic compounds. The discussion covers:
- The DMAIC (Define, Measure, Analyze, Improve, Control) methodology and its practical applications
- Quality by Design (QbD) principles and risk management frameworks
- Real-world case studies, including improving terpene profile consistency in cannabis extracts and controlling impurities in pharmaceutical manufacturing
The episode emphasizes how these quality control principles help manufacturers maintain consistency, safety, and efficacy in natural product manufacturing while meeting regulatory requirements.